Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

STTK Shattuck Labs, Inc.

Post-Mkt 10-02 16:23:37 EDT

6.73

-0.11

-1.61%

盘后6.73

+0.000.00%

16:20 EDT

High7.09	Low6.54	Vol1.84M
Open7.02	D1 Closing6.84	Amplitude8.04%
Mkt Cap675.44M	Tradable Cap456.02M	Total Shares100.36M
T/O12.42M	T/O Rate2.72%	Tradable Shares67.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"STTK","market":"US","secType":"STK","nameCN":"Shattuck Labs, Inc.","latestPrice":6.73,"timestamp":1790971200000,"preClose":6.84,"halted":0,"volume":1843619,"hourTrading":{"tag":"盘后","latestPrice":6.73,"preClose":6.73,"latestTime":"16:20 EDT","volume":31019,"amount":208757.87000000002,"timestamp":1790972400098,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.016081871345029156,"floatShares":67759100,"shares":100363253,"eps":-0.500978,"marketStatus":"Post-Mkt","change":-0.11,"latestTime":"10-02 16:23:37 EDT","open":7.02,"high":7.09,"low":6.54,"amount":12415134.987709,"amplitude":0.080409,"askPrice":7.09,"askSize":36,"bidPrice":6.52,"bidSize":26,"shortable":3,"etf":0,"ttmEps":-0.500978,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":6.84,"preHourTrading":{"tag":"盘前","latestPrice":7.12,"preClose":6.84,"latestTime":"09:28 EDT","volume":39,"amount":267.989982,"timestamp":1790947728064,"change":0.28,"changeRate":0.040936,"amplitude":0.045322},"postHourTrading":{"tag":"盘后","latestPrice":6.73,"preClose":6.73,"latestTime":"16:20 EDT","volume":31019,"amount":208757.87000000002,"timestamp":1790972400098,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.123057,"impliedVol":1.3703,"impliedVolPercentile":0.4422},"requestUrl":"/m/hq/s/STTK/wiki","defaultTab":"wiki","newsList":[{"id":"2672107147","title":"Shattuck Labs Price Target Raised to $14.00/Share from $11.00 by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2672107147","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672107147?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:59","pubTimestamp":1790953140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/STTK/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711857","title":"Piper Sandler Remains a Buy on Shattuck Labs (STTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711857?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940940,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Shattuck Labs today and set a price target of $15.00. Rahimi covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-shattuck-labs-sttk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-shattuck-labs-sttk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4139","BK4588","LABU","STTK","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672719133","title":"Shattuck Labs price target raised to $19 from $17 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2672719133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672719133?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:15","pubTimestamp":1790939709,"startTime":"0","endTime":"0","summary":"Needham analyst Joseph Stringer raised the firm’s price target on Shattuck Labs (STTK) to $19 from $17 and keeps a Buy rating on the shares after t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shattuck-labs-price-target-raised-to-19-from-17-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shattuck-labs-price-target-raised-to-19-from-17-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672667719","title":"Shattuck Labs Inc : Needham Raises Target Price to $19 from $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2672667719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672667719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:12","pubTimestamp":1790939530,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O10X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672162716","title":"Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672162716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672162716?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:30","pubTimestamp":1790937019,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Shattuck Labs (STTK) and Atricure (ATRC). Shattuck...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-shattuck-labs-sttk-and-atricure-atrc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-shattuck-labs-sttk-and-atricure-atrc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATRC","LABU","BK4588","XLV","BK4585","BK4139","HCSG","LU0128526141.USD","LU0029874061.USD","BK4581","STTK","XBI","BK4082","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672750560","title":"Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672750560","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672750560?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:25","pubTimestamp":1790861154,"startTime":"0","endTime":"0","summary":"Shattuck Labs (STTK) has an average rating of buy and mean price target of $15.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752746","title":"Shattuck Labs (STTK) Receives a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752746?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:36","pubTimestamp":1790858198,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst reiterated a Buy rating on Shattuck Labs today and set a price target of $16.00. Shattuck Labs has an analyst consensus of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/shattuck-labs-sttk-receives-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/shattuck-labs-sttk-receives-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754164","title":"Shattuck Labs Plans Phase 2 Trial of Chronic Inflammatory Skin Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754164","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754164?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:58","pubTimestamp":1790855923,"startTime":"0","endTime":"0","summary":"Shattuck Labs  said Thursday it plans to evaluate its experimental drug, SL-325, in a phase 2 trial for patients with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin condition.The company said the trial is expected to enroll about 150 patients.The primary goal is to measure the percentage of patients achieving a 50% reduction in abscesses and inflammatory nodules without an increase in abscesses or draining tunnels at Week 16. The company said it also plans to assess a 75% reduction, safety and tolerability.The company expects to submit an investigational new drug application this month, with Week 16 data expected in H1 2028.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672759770","title":"Shattuck Labs Names Shoba Ravichandran Senior Vice President, Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2672759770","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672759770?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852437,"startTime":"0","endTime":"0","summary":"Shattuck Labs names Shoba Ravichandran senior vice president, clinical developmentShattuck Labs named Shoba Ravichandran as senior vice president, clinical development to lead the SL-325 hidradenitis ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLblNcch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","STTK","BK4112","BK4139","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672836751","title":"Shattuck Labs - Phase 2 Trial to Start in 2026; 16-Week Data Expected in H1 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2672836751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672836751?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA18DBBJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751837","title":"Shattuck Labs - Existing Cash Expected to Fund Operations into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751837?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA18DBBJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751835","title":"Shattuck Labs - to Initiate Phase 2 Trial of Sl-325 in Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751835?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA18DBBJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672518327","title":"Shattuck Labs - Ind Submission for Phase 2 Trial Expected in October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672518327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672518327?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA18DBBJ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672275976","title":"Shattuck Labs Announces Phase 2 Clinical Trial of Sl-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.d., as Senior Vice President, Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2672275976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672275976?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:00","pubTimestamp":1790852400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA18DBBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789515","title":"Pantginis Maintains Buy on Shattuck as Merck TL1A/DR3 Data De-Risk SL-325; Price Target Reiterated at $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789515","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789515?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:45","pubTimestamp":1790786718,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Shattuck Labs, retaining the price target of $14.00. Joseph Pantginis has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pantginis-maintains-buy-on-shattuck-as-merck-tl1a-dr3-data-de-risk-sl-325-price-target-reiterated-at-14-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pantginis-maintains-buy-on-shattuck-as-merck-tl1a-dr3-data-de-risk-sl-325-price-target-reiterated-at-14-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439439","title":"Shattuck Labs management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439439?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:50","pubTimestamp":1790196610,"startTime":"0","endTime":"0","summary":"Meeting to be held on October 1 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shattuck-labs-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shattuck-labs-management-to-meet-with-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664184941","title":"Shattuck Labs Announces Participation in Upcoming September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664184941","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664184941?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:05","pubTimestamp":1788379500,"startTime":"0","endTime":"0","summary":"AUSTIN, Texas and DURHAM, N.C., Sept.  02, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355491/0/en/shattuck-labs-announces-participation-in-upcoming-september-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275647","title":"Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275647?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:39","pubTimestamp":1787571577,"startTime":"0","endTime":"0","summary":"Shattuck Labs (STTK) has an average rating of buy and mean price target of $15, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027324","title":"Shattuck Labs Inc : Raymond James Initiates Coverage with Strong Buy Rating; Target Price $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661027324?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:18","pubTimestamp":1787570314,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","STTK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661150278","title":"Shattuck Labs initiated with a Strong Buy at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2661150278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661150278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:35","pubTimestamp":1787567741,"startTime":"0","endTime":"0","summary":"Raymond James analyst Martin Auster initiated coverage of Shattuck Labs (STTK) with a Strong Buy rating and $18 price target SL-325 could offer a d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/shattuck-labs-initiated-with-a-strong-buy-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/shattuck-labs-initiated-with-a-strong-buy-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2265009873.SGD","BK4127","LU0971096721.USD","BK4585","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","STTK","LU1363072403.SGD","LU1804176565.USD","IE00B3QW5Z07.USD","RJF"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shattucklabs.com","stockEarnings":[{"period":"1week","weight":0.084},{"period":"1month","weight":-0.0044},{"period":"3month","weight":-0.0298},{"period":"6month","weight":0.0654},{"period":"1year","weight":1.8739},{"period":"ytd","weight":0.874}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.152423},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039398},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.072166},{"month":4,"riseRate":0.833333,"avgChangeRate":0.089273},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.175666},{"month":6,"riseRate":0.666667,"avgChangeRate":0.01458},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.078721},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.026646},{"month":9,"riseRate":0.166667,"avgChangeRate":0.146801},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.139735},{"month":11,"riseRate":0.5,"avgChangeRate":-0.021423},{"month":12,"riseRate":1,"avgChangeRate":0.656999}],"exchange":"NASDAQ","name":"Shattuck Labs, Inc.","nameEN":"Shattuck Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shattuck Labs, Inc.,STTK,Shattuck Labs, Inc.股票,Shattuck Labs, Inc.股票老虎,Shattuck Labs, Inc.股票老虎国际,Shattuck Labs, Inc.行情,Shattuck Labs, Inc.股票行情,Shattuck Labs, Inc.股价,Shattuck Labs, Inc.股市,Shattuck Labs, Inc.股票价格,Shattuck Labs, Inc.股票交易,Shattuck Labs, Inc.股票购买,Shattuck Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}